1α,25-Dihydroxyvitamin D3 Modulates the Hair-Inductive Capacity of Dermal Papilla Cells: Therapeutic Potential for Hair Regeneration

    Noriyuki Aoi, Keita Inoue, Toshihiro Chikanishi, Ryoji Fujiki, Hiroyasu Yamamoto, Harunosuke Kato, Hikaru Eto, Kentaro Doi, Satoshi Itami, Shigeaki Kato, Kotaro Yoshimura
    New to cholecalciferol? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this study, VD(3) pretreatment increased hair follicle formation in a rat model by promoting dermal papilla cell differentiation, suggesting potential for hair regeneration therapy.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The 2012 study investigated the effects of 1α,25-Dihydroxyvitamin D3 (VD3) on dermal papilla cells (DPCs), which are known to induce hair growth. The researchers found that VD3 suppressed DPC proliferation in a dose-dependent, non-toxic manner and significantly increased the expression of Wnt10b, a gene involved in hair growth initiation. This effect was specific to DPCs and not observed in human dermal fibroblasts. In a rat model, VD3 pretreatment significantly enhanced hair follicle regeneration, with more outgrowing hair shafts and higher maturation of regenerated follicles. The study concluded that VD3 could promote functional differentiation of DPCs and could be useful in preserving the hair follicle-inductive capacity of cultured DPCs for hair regeneration therapies.
    Discuss this study in the Community →

    Research cited in this study

    16 / 16 results